Market Overview

Credit Suisse Reinstates Coverage on Corcept Therapeutics at Outperform, Lowers PT from $6 to $4

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CORT

DateFirmActionFromTo
Dec 2015Janney CapitalInitiates Coverage onBuy
Apr 2015FBR CapitalInitiates Coverage onOutperform
Mar 2015Piper JaffrayUpgradesNeutralOverweight

View More Analyst Ratings for CORT
View the Latest Analyst Ratings

Posted-In: Price Target Analyst Ratings

 

Related Articles (CORT)